Sigurd C. Kirk - 23 Sep 2022 Form 4 Insider Report for Aravive, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 23 Sep 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Sep 2022, 16:08:04 UTC
Prior SEC filing: 13 Sep 2021
Next SEC filing: 09 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Abel Svitavsky, Attorney-In-Fact

Key filing fact

Sigurd C. Kirk filed Form 4 for Aravive, Inc. on 26 Sep 2022.

Key facts

This page summarizes Sigurd C. Kirk's Form 4 filing for Aravive, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Sep 2022, 16:08.

Change

Previous filing in this sequence was filed on 13 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARAV transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +97,063
Change %
Price: $0.000000
Shares after: 97,063
Date: 23 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 97,063
Exercise price: $0.9152
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders.